Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.42−0.06 (-4.05%)
Close on Nov 17, 2026Market cap $53.14MP/E –Yield –
Tenax Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Tenax Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 0.6× a year earlier. Over the last 4 years it ranged from 0.1× to 464.7×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −0.3 |
| 2025 | Dec 31, 2025 | 0.7× | +0.5 |
| 2024 | Dec 31, 2024 | 0.2× | −46.2 |
| 2023 | Dec 29, 2023 | 46.4× | −298.7 |
| 2022 | Apr 29, 2022 | 345.1× | +6.6 |
| 2017 | Apr 28, 2017 | 338.6× | – |
See a number that looks wrong?